Low Fructose Diet in Diabetes Type 2

November 20, 2017 updated by: Dr Azita Hekmatdoost, National Nutrition and Food Technology Institute

Effects of Low Fructose Diet on Glycemic Control in Patients With Type 2 Diabetes

Diabetes is one of the most common and chronic diseases in the world, with the prevalence and incidence of this disease rising in most societies, especially in Iran. Suitable treatments for type 2 diabetes include changing lifestyle with exercise, nutrition, and drug use. New research suggests that added sugar, especially fructose, is the main trigger for diabetes and pre-diabetes even more potent than other carbohydrates. Fructose has a low glycemic index (23μg =) and slowly increases blood glucose levels. Therefore, it is thought that replacing fructose instead of glucose can have a positive effect on glycemic control of diabetic patients..

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age of 70-40 years
  2. body mass index(BMI) between 18.5 and 27
  3. Type 2 diabetes People who only control their diabetes by using glucose lowering tablets Type 2 diabetes (1 to 10 years)

Exclusion Criteria:

  1. Pregnancy and lactation
  2. Thyroid gland disorders
  3. Kidney disease and inflammation
  4. Follow the weight loss regimen 6 months before starting the study
  5. Usage of fatty and fatty foods, fiber powder Vitamin A Mineral Supplements, Omega 3
  6. Taking glucocorticoid drugs and non-steroidal anti-inflammatory drugs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention group
Eight weeks of low fructose diet with a maximum of 12 g of fructose
No Intervention: control group
Eight weeks of regular diabetic diet with a 15%pro 30%fat 55%CHO

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
fasting blood suger(FBS)
Time Frame: 8 weeks
8 weeks
Homeostatic model assessment and insulin resistance(HOMA-IR)
Time Frame: 8weeks
8weeks
insulin
Time Frame: 8 weeks
8 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Blood pressure
Time Frame: 8 weeks
8 weeks
Triglyceride
Time Frame: 8 weeks
8 weeks
LDL-C
Time Frame: 8 weeks
8 weeks
HDL-C
Time Frame: 8 weeks
8 weeks
Total cholestrole
Time Frame: 8 weeks
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

October 1, 2017

Study Completion (Anticipated)

November 30, 2017

Study Registration Dates

First Submitted

November 13, 2017

First Submitted That Met QC Criteria

November 20, 2017

First Posted (Actual)

November 24, 2017

Study Record Updates

Last Update Posted (Actual)

November 24, 2017

Last Update Submitted That Met QC Criteria

November 20, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 93567

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fructose Metabolism Disorder

Clinical Trials on low frutose diet

Subscribe